Until this week, Invitrogen’s method for quickly expanding its product pipeline — and its top line — was via acquisition.

Highlighted by its $325 million purchase of Molecular Probes in August 2003, the company has expanded its product offerings like an accordion player stretching his arms, buying and integrating eight companies over the past two years to create a broader multiplatform product portfolio of molecular biology instruments, reagents, and services.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.